- Home
- AVIR vs NRC Comparison
AVIR vs NRC Comparison
Compare AVIR & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | NRC |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.5M | 390.8M |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AVIR | NRC |
|---|---|---|
| Price | $4.19 | $18.86 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 286.4K | 94.6K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | 3.00 | ★ 4707.69 |
| EPS | N/A | ★ 0.14 |
| Revenue | ★ $351,367,000.00 | $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $135.21 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $2.78 | $11.01 |
| 52 Week High | $6.45 | $22.79 |
Technical Indicators
Market Signals| Indicator | AVIR | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 25.08 | 59.09 |
| Support Level | $3.32 | $14.76 |
| Resistance Level | $4.34 | $19.42 |
| Average True Range (ATR) | 0.26 | 0.99 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 6.70 | 85.15 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.